Indications and uses
How to Use: After using our clear toner, evenly apply an appropriate amount to the skin.
How to Use: After using our clear toner, evenly apply an appropriate amount to the skin.
How to Use: After using our clear toner, evenly apply an appropriate amount to the skin.
Active Ingredient: GLYCERIN 25.4%
Inactive Ingredients:
SACCHAROMYCES FERMENT, BUTYLENE GLYCOL, NIACINAMIDE, WATER, 1,2-HEXANEDIOL, CYCLOMETHICONE, DIMETHICONOL, PEG-40 HYDROGENATED CASTOR OIL, CENTELLA ASIATICA EXTRACT, CARBOMER, ARCTIUM LAPPA ROOT EXTRACT, PIPER METHYSTICUM LEAF/ROOT/STEM EXTRACT, PORTULACA OLERACEA EXTRACT, PHELLINUS LINTEUS EXTRACT, SCIADOPITYS VERTICILLATA ROOT EXTRACT, XANTHAN GUM, SODIUM HYDROXIDE, ROSMARINUS OFFICINALIS (ROSEMARY) LEAF EXTRACT, CHAMOMILLA RECUTITA (MATRICARIA) FLOWER EXTRACT, CITRUS AURANTIUM DULCIS (ORANGE) FRUIT WATER, PHELLODENDRON AMURENSE BARK EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, ALTHAEA OFFICINALIS LEAF/ROOT EXTRACT, HIBISCUS ESCULENTUS FRUIT EXTRACT, LAVANDULA ANGUSTIFOLIA (LAVENDER) EXTRACT, LINUM USITATISSIMUM (LINSEED) SEED EXTRACT, OCIMUM BASILICUM (BASIL) FLOWER/LEAF EXTRACT, PUERARIA THUNBERGIANA ROOT EXTRACT, CNIDIUM OFFICINALE ROOT EXTRACT, GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT, PAEONIA LACTIFLORA ROOT EXTRACT, ANTHEMIS NOBILIS FLOWER EXTRACT, FOENICULUM VULGARE (FENNEL) FRUIT EXTRACT, HOUTTUYNIA CORDATA EXTRACT, PHENOXYETHANOL, TRISODIUM EDTA, AGAR, HYDROGENATED LECITHIN, ALGIN, ALLANTOIN, BISABOLOL, KERATIN AMINO ACIDS, CITRUS GRANDIS (GRAPEFRUIT) PEEL OIL, SOLUBLE COLLAGEN, PANTHENOL, OLEA EUROPAEA (OLIVE) FRUIT OIL, SODIUM HYALURONATE, ALOE BARBADENSIS LEAF JUICE, ARGANIA SPINOSA KERNEL OIL, CITRUS AURANTIFOLIA (LIME) OIL, MICA, RIBES NIGRUM (BLACK CURRANT) SEED OIL, DICAPRYLYL CARBONATE, FOLIC ACID, CERAMIDE 3, TITANIUM DIOXIDE, SUCROSE DISTEARATE, TOCOPHEROL, CHOLESTEROL, RAFFINOSE, ROSE FLOWER OIL, ILLICIUM VERUM (ANISE) FRUIT/SEED OIL, TROMETHAMINE, PALMITOYL PENTAPEPTIDE-4
Purpose: This essence with the ingredients of vitamin capsule ampoule makes the skin clear and transparent.
Cautions:
For external use only.
Avoid contact with eyes and mouth.
Discontinue use if signs of irritation or rash appear.
Keep out of reach of children.
Replace the cap after use.
KEEP OUT OF REACH OF CHILDREN
How to Use: After using our clear toner, evenly apply an appropriate amount to the skin.
How to Use: After using our clear toner, evenly apply an appropriate amount to the skin.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8809344261281 | GTIN-13: 8809344261281 EAN-13: 8809344261281 GTIN storage (14 digits): 08809344261281 | the first ampoule essence carton.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51346-080-01 | 2021-07-10 | C162847 | 48780-1 | 9d75b9d0-3f55-f424-e053-dadaa90a57ce | bd372d94-ad92-42da-bb35-ac61a76f72fb |
| 51346-080-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3f55-f424-e053-dadaa90a57ce | bd372d94-ad92-42da-bb35-ac61a76f72fb |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51346-080 | 51346-080-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | ACTIM |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| NIACINAMIDE | 25X51I8RD4 | IACT |
| WATER | 059QF0KO0R | IACT |
| CYCLOMETHICONE | NMQ347994Z | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, FILM COATED / ORAL | 0.08 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOZENGE / ORAL | 1264 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GEL / TOPICAL | 58 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM / TOPICAL | 13 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / TOPICAL | 0.11 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION / ORAL | 450 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | SOLUTION / TOPICAL | 11.57 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | AEROSOL, FOAM / TOPICAL | 5.26 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / OPHTHALMIC | 0.6 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | CREAM, AUGMENTED / TOPICAL | 7.6 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SOLUTION / ORAL | 10 mg/5ml | ||
| NIACINAMIDE | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER / ORAL | 275 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | ENEMA / RECTAL | 150 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f6cc8d19-866b-4ea6-a27e-0244b9cce3fa | bd372d94-ad92-42da-bb35-ac61a76f72fb | 2021-07-09 | Warnings | bd372d94-ad92-42da-bb35-ac61a76f72fb |
Adverse event summaries are temporarily unavailable. Other product information remains available.